Prolotherapy for early osteoarthritis knee

  • Dr Sarvesh Jain Assistant Professor, Department of Anesthesia, Bundelkhand Medical College, Sagar, India
  • Dr Rajesh Jain Assistant Professor, Department of Orthopedics, Bundelkhand Medical College, Sagar, India
  • Dr KK Arora Professor, Department Of Anesthesia, Bundelkhand Medical College, Sagar, India
Keywords: Dextrose Prolotherapy, Knee Osteoarthritis, Prolotherapy

Abstract

Introduction: Osteoarthritis is most prevalent arthritis in older patients. Present study is to evaluate efficacy of dextrose prolotherapy for treatment of early knee osteoarthritis.

Material & Method: This study was done at Bundelkhand Medical College, Sagar. In our study we studied 38 patients of more than 55 years of age. For treatment of Knee OA, 3 sitting of prolotherapy were given one month apart and patient followed up for 1 year.

Results: 76% patients showed improvement on second follow-up. On third follow up 89% showed improvement. On further follow up at 6 months 81% of patients were symptomatically improved. These patients remained symptomatically better even at the conclusion of study.

Discussion: Definitive mechanism of action of prolotherapy is unknown but probable mechanism is, hypertonic dextrose induced growth factor release and connective tissue healing thereafter.

Conclusion: Dextrose prolotherapy injection is safe, reliable and long lasting treatment modality for early osteoarthritis

Downloads

Download data is not yet available.

References

1. Hashan manaletal.Clinical features and pathogenetic mechanisms of osteoarthritis of the hip and kneeI:BCMJ.2010; 52(8):393-398.

2 David Rabago, Jeffrey J. Patterson, Joel Jay Baumgartner. Prolotherapy. Jan 2011: 113-130

3. David Rabago, Jeffrey J.et al. Dextrose Prolotherapyfor Knee Osteoarthritis: A Randomized Controlled Trial Ann Fam Med. 2013;11(3): 229-237.

4.Hackett GS, Hemwall GA,Montgomery GA Ligament and tendon relaxation treated by prolotherapy. 5th ed. Oak Park: Gustav A. Hemwall;1993.p.175

5. Kellgren JH, Jeffrey MR, Ball J The Epidemiology of Chronic Rheumatism. Atlas of Standard Radiographs of Arthritis. Oxford, UK:Blackwell Scientific Publications; 1963.p.198

6. Dong Rak Kwon and Gi Young Park.Intra-Articular Injections for the Treatment ofOsteoarthritis: Focus on the ClinicalUse of Several Regimens. Available at:
http://www.researchgate.net/publication/221926910_Int
ra-Articular_Injections_for_the_Treatment_of_Osteoarthrit is_Focus_on_the_Clinical_Use_of_Several_Regimens.Cited on13th April 2014.

7.Jensen KT, Rabago DP, Best TM, Patterson JJ, Vanderb y R Jr.Early inflammatory response of knee ligaments to prolotherapy in a rat model. J Ortho Res. 2008;26(6):816–823.

8. Rabago D, Patterson JJ, Mundt M, et al. Dextrose prolotherapy for knee osteoarthritis: a randomized controlled trial. Ann Fam Med. 2013;11:229-237.

9. Reeves KD Hassanein K. Randomized prospective double-blind placebo-controlled study of dextrose prolotherapy for knee osteoarthritis with or without ACL laxity. Alt Ther Hlth Med 2000;6(2):37-46.

10. Dumais R, Benoit C, Dumais A, Babin L, Bordage R, de Arcos C, Allard J, Bélanger M. Effect of Regenerative Injection Therapy on Function and Pain in Patients with Knee Osteoarthritis: A Randomized Crossover Study. Pain Med. 2012 Jul 3. doi:10.1111/j.1526-4637.2012.01422.x.
CITATION
DOI: 10.17511/ijmrr.2014.i04.02
Published: 2014-08-31
How to Cite
1.
Jain S, Jain R, Arora K. Prolotherapy for early osteoarthritis knee. Int J Med Res Rev [Internet]. 2014Aug.31 [cited 2024Dec.22];2(4):279- 282. Available from: https://ijmrr.medresearch.in/index.php/ijmrr/article/view/106
Section
Original Article